TY  - JOUR
AU  - Buxeda, Anna
AU  - Arias-Cabrales, Carlos
AU  - Perez-Saez, Maria Jose
AU  - Cacho, Judit
AU  - Cabello-Pelegrin, Sheila
AU  - Melilli, Edoardo
AU  - Aladren, Maria Jose
AU  - Galeano, Cristina
AU  - Lorenzo, Inmaculada
AU  - Mazuecos, Auxiliadora
AU  - Saura, Isabel Maria
AU  - Franco, Antonio
AU  - Ruiz-Fuentes, Maria Del Carmen
AU  - Sanchez-Camara, Luis Alberto
AU  - Siverio, Orlando
AU  - Martin, Maria Luisa
AU  - Gonzalez-Garcia, Elena
AU  - Lopez, Veronica
AU  - Martin-Moreno, Paloma Leticia
AU  - Moina, Iñigo
AU  - Moral-Berrio, Esperanza
AU  - Moreso, Francesc
AU  - Portoles, Jose Maria
AU  - Santana-Estupiñan, Raquel
AU  - Zarraga, Sofia
AU  - Canal, Cristina
AU  - Sanchez-Alvarez, Emilio
AU  - Pascual, Julio
AU  - Crespo, Marta
PY  - 2021
DO  - 10.1016/j.ekir.2021.06.023
UR  - http://hdl.handle.net/10668/18190
T2  - Kidney international reports
AB  - Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury have been reported. Scant data are available on...
LA  - en
PB  - Elsevier
KW  - SARS-CoV2l
KW  - Acute kidney injury
KW  - Immunosuppression
KW  - Kidney transplantation
KW  - Remdesivir
KW  - Kidney Transplantation
KW  - Respiration, Artificial
KW  - COVID-19
KW  - Acute Kidney Injury
KW  - Digestive System Diseases
KW  - Antiviral Agents
KW  - Cohort Studies
TI  - Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19.
TY  - research article
VL  - 6
ER  -